Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017536 (
giardiasis
)
1,714
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Twelve Giardia duodenalis-infected Holstein dairy calves were allocated into a treatment (n=6) and placebo group (n=6) according to pre-study faecal cyst counts. Calves in the treatment group received an oral dose of 5 mg/kg fenbendazole once daily for 3 days, while placebo calves received a sterile saline solution. Calves were euthanised 7 days following the initiation of treatment and intestinal were collected and prepared for trophozoite quantitation, histology, electron microscopy, and disaccharidase assays. In all calves treated with fenbendazole, intestinal trophozoites were below detection limits, while in saline-treated calves, trophozoites were observed in all intestinal segments. Histologically, no significant difference was observed between treatment groups with respect to intestinal villus height or crypt depth. However, a significant decline in the number of intraepithelial lymphocytes (IEL) was observed in fenbendazole-treated calves when compared with placebo-treated calves in the duodenum (13.9+/-1.2 vs. 17.0+/-1.1 IEL/100 enterocytes) and jejunum (21.6+/-0.8 vs. 30.7+/-1.0 IEL/100 enterocytes). In addition, measurements from
TEM
micrographs demonstrated a significant increase in microvillus surface area in the jejunum of fenbendazole-treated calves compared with saline-treated calves (31.2+/-10.2 vs. 22.8+/-7.6 microm(2)). This increase in microvillus surface area was also associated with an increase in jejunal maltase activity in fenbendazole-treated calves compared with calves treated with saline. These results demonstrate that fenbendazole is an effective treatment for
giardiasis
in calves. fenbendazole treatment eliminated Giardia trophozoites from the small intestine of calves resulting in increased microvillus surface area and greater intestinal enzyme activity. This study also demonstrates that the pathogenesis of
giardiasis
in calves is similar to that observed in humans and laboratory animals, and provides further evidence that Giardia is a pathogen of cattle with potential economic importance.
...
PMID:Giardiasis in dairy calves: effects of fenbendazole treatment on intestinal structure and function. 1116 74
Mirazid -a purified oleo-resin extract derived from myrrh- with previously proved trematocidal activity, has been recently reported to be also effective against protozoa like Trichomonas vaginalis and cryptosporidium in humans. This experimental study aimed at investigating the possible therapeutic effect of mirazid on experimental
Giardia lamblia infection
in albino rats, using tinidazole as a therapeutic control. Results proved the efficacy of mirazid, as indicated by a 100% reduction in parasite- load of both intestinal and fecal parasitic counts, a direct toxic effect on Giardia trophozoite as revealed by SEM and
TEM
in form of cell membrane erosions together with increased cytoplasmic vaculation and dissociation, and also by reversal of the observed mucosal damage associated with Giardia after complete treatment. Starting trophozoite invasion of the mucosa was also demonstrated by
TEM
; its mechanism and possible pathogenic effect in
giardiasis
were discussed.
...
PMID:Effect of mirazid (Commiphora molmol) on experimental giardiasis. 2163 51